Literature DB >> 22365536

In vivo spreading of tau pathology.

Claudio Soto1.   

Abstract

Recent findings have suggested that tau pathology may spread in the brain by a prion-like mechanism. In this issue of Neuron, de Calignon et al. (2012) recreated an early stage of neurofibrillary tangle pathology to show that tau aggregates initially generated in a circumscribed area spread throughout the brain and lead to neurodegeneration.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Year:  2012        PMID： 22365536     DOI： 10.1016/j.neuron.2012.02.006

Source DB:  PubMed          Journal:  Neuron        ISSN： 0896-6273            Impact factor:   17.173


  10 in total

1.  Cerebrovascular inflammation is associated with tau pathology in Guam parkinsonism dementia.

Authors:  Petra Majerova; Ralph M Garruto; Andrej Kovac
Journal:  J Neural Transm (Vienna)       Date:  2018-04-26       Impact factor: 3.575

Review 2.  Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Biochem Pharmacol       Date:  2014-01-10       Impact factor: 5.858

3.  Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau In Vivo.

Authors:  Tomas Ondrejcak; Igor Klyubin; Grant T Corbett; Graham Fraser; Wei Hong; Alexandra J Mably; Matthew Gardener; Jayne Hammersley; Michael S Perkinton; Andrew Billinton; Dominic M Walsh; Michael J Rowan
Journal:  J Neurosci       Date:  2018-10-24       Impact factor: 6.167

4.  Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.

Authors:  Selcuk A Tanik; Christine E Schultheiss; Laura A Volpicelli-Daley; Kurt R Brunden; Virginia M Y Lee
Journal:  J Biol Chem       Date:  2013-03-26       Impact factor: 5.157

5.  Antibody uptake into neurons occurs primarily via clathrin-dependent Fcγ receptor endocytosis and is a prerequisite for acute tau protein clearance.

Authors:  Erin E Congdon; Jiaping Gu; Hameetha B R Sait; Einar M Sigurdsson
Journal:  J Biol Chem       Date:  2013-10-25       Impact factor: 5.157

6.  Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies.

Authors:  Petra Majerova; Alena Michalicova; Martin Cente; Jozef Hanes; Jozef Vegh; Agnes Kittel; Nina Kosikova; Viera Cigankova; Sandra Mihaljevic; Santosh Jadhav; Andrej Kovac
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

7.  Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.

Authors:  Yanxing Chen; Shuai Zhao; Ziqi Fan; Zheyu Li; Yueli Zhu; Ting Shen; Kaicheng Li; Yaping Yan; Jun Tian; Zhirong Liu; Baorong Zhang
Journal:  Alzheimers Res Ther       Date:  2021-02-09       Impact factor: 6.982

Review 8.  Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.

Authors:  Cody Slater; Qi Wang
Journal:  Clin Transl Med       Date:  2021-04

9.  Nonlocal models in the analysis of brain neurodegenerative protein dynamics with application to Alzheimer's disease.

Authors:  Swadesh Pal; Roderick Melnik
Journal:  Sci Rep       Date:  2022-05-05       Impact factor: 4.996

10.  A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity.

Authors:  Zeshan Ahmed; Jane Cooper; Tracey K Murray; Katya Garn; Emily McNaughton; Hannah Clarke; Samira Parhizkar; Mark A Ward; Annalisa Cavallini; Samuel Jackson; Suchira Bose; Florence Clavaguera; Markus Tolnay; Isabelle Lavenir; Michel Goedert; Michael L Hutton; Michael J O'Neill
Journal:  Acta Neuropathol       Date:  2014-02-16       Impact factor: 17.088
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.